Correlation Between CPU SOFTWAREHOUSE and Astellas Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CPU SOFTWAREHOUSE and Astellas Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CPU SOFTWAREHOUSE and Astellas Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CPU SOFTWAREHOUSE and Astellas Pharma, you can compare the effects of market volatilities on CPU SOFTWAREHOUSE and Astellas Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CPU SOFTWAREHOUSE with a short position of Astellas Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of CPU SOFTWAREHOUSE and Astellas Pharma.

Diversification Opportunities for CPU SOFTWAREHOUSE and Astellas Pharma

0.22
  Correlation Coefficient

Modest diversification

The 3 months correlation between CPU and Astellas is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding CPU SOFTWAREHOUSE and Astellas Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Astellas Pharma and CPU SOFTWAREHOUSE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CPU SOFTWAREHOUSE are associated (or correlated) with Astellas Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Astellas Pharma has no effect on the direction of CPU SOFTWAREHOUSE i.e., CPU SOFTWAREHOUSE and Astellas Pharma go up and down completely randomly.

Pair Corralation between CPU SOFTWAREHOUSE and Astellas Pharma

Assuming the 90 days trading horizon CPU SOFTWAREHOUSE is expected to under-perform the Astellas Pharma. In addition to that, CPU SOFTWAREHOUSE is 1.98 times more volatile than Astellas Pharma. It trades about -0.03 of its total potential returns per unit of risk. Astellas Pharma is currently generating about -0.04 per unit of volatility. If you would invest  1,487  in Astellas Pharma on September 3, 2024 and sell it today you would lose (514.00) from holding Astellas Pharma or give up 34.57% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

CPU SOFTWAREHOUSE  vs.  Astellas Pharma

 Performance 
       Timeline  
CPU SOFTWAREHOUSE 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in CPU SOFTWAREHOUSE are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain technical and fundamental indicators, CPU SOFTWAREHOUSE may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Astellas Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Astellas Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's technical indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

CPU SOFTWAREHOUSE and Astellas Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CPU SOFTWAREHOUSE and Astellas Pharma

The main advantage of trading using opposite CPU SOFTWAREHOUSE and Astellas Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CPU SOFTWAREHOUSE position performs unexpectedly, Astellas Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Astellas Pharma will offset losses from the drop in Astellas Pharma's long position.
The idea behind CPU SOFTWAREHOUSE and Astellas Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.